Pharma Journalist - Page 36 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

FDA Approves Glaukos’ Epioxa, First Incision-Free Drug for Keratoconus

Roche’s Tecentriq Extends Survival in Bladder Cancer Using ctDNA-Guided Approach

FDA Approves Roche’s Gazyva for Lupus Nephritis with Streamlined Dosing

Lundbeck and Contera Partner to Develop RNA-Based Neurology Drugs

FDA Approves Roche’s Gazyva for Lupus Nephritis, Offering New Hope for Patients

GSK and ViiV Healthcare Pledge £6 Million to Boost Global Fight Against HIV, TB and Malaria

Roche’s Giredestrant Combo Cuts Breast Cancer Progression Risk by Up to 62% in Phase III Trial

Merck Partners with U.S. Government to Slash IVF Drug Prices, Expand Access

Tubulis Raises €308M to Advance Antibody-Drug Conjugate Pipeline

Novo Nordisk Acquires Rights to Zaltenibart in $2.1B Rare Disease Deal with Omeros